Suchergebnisse - "Capdevila, Jaume"

PubPharm (157)

1

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology : A Subgroup Analysis of the COSMIC-311 Study

enthalten in: Thyroid : official journal of the American Thyroid Association | 2024

von Capdevila, J. | Krajewska, J. | Hernando, J. | +13

2

Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer

enthalten in: Radiology. Artificial intelligence | 2024

von Prior, O. | Macarro, C. | Navarro, V. | +17

CommentIn: Radiol Artif Intell. 2024 Mar;6(2):e230547. - PMID 38416038

3

A Phase Ib Study of the DNA-PK Inhibitor Peposertib Combined with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Romesser, P. | Capdevila, J. | Garcia-Carbonero, R. | +10

4

Methodology of the SORENTO clinical trial : a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET

enthalten in: Trials | 2024

von Singh, S. | Ferone, D. | Capdevila, J. | +8

5

Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival

enthalten in: European journal of endocrinology | 2024

von La Salvia, A. | Lens-Pardo, A. | López-López, A. | +17

6

Total neoadjuvant therapy with or without aflibercept in rectal cancer : 3-year results of GEMCAD-1402

enthalten in: Journal of the National Cancer Institute | 2023

von Pesántez, D. | Ten Hoorn, S. | Machado, I. | +19

CommentIn: J Natl Cancer Inst. 2023 Oct 18;:. - PMID 37851864

7

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

enthalten in: The New England journal of medicine | 2023

von Hadoux, J. | Elisei, R. | Brose, M. | +122

8

Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment

enthalten in: Current oncology reports | 2023

von Andreatos, N. | McGarrah, P. | Sonbol, M. | +4

9

A pan-cancer clinical platform to predict immunotherapy outcomes and prioritize immuno-oncology combinations in early-phase trials

enthalten in: Med (New York, N.Y.) | 2023

von Hernando-Calvo, A. | Vila-Casadesús, M. | Bareche, Y. | +35

10

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery : A 5-Year Follow-up of the RAPIDO Trial

enthalten in: Annals of surgery | 2023

von Dijkstra, E. | Nilsson, P. | Hospers, G. | +15

CommentIn: Ann Surg Open. 2023 Jun 02;4(2):e288. - PMID 37601460

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]